Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 06/01/2010
PIL Serevent Accuhaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 20/08/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 17/04/2009 and displayed until 20/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 07/11/2007 and displayed until 17/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 25/05/2005 and displayed until 07/11/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/02/2004 and displayed until 25/05/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 23/10/2003 and displayed until 17/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 23/04/2001 and displayed until 23/10/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 24/11/2000 and displayed until 23/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   salmeterol xinafoate